Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxelMichael Millward, Matthew A. Spear, Paul N. Mainwaring et al.|Investigational New Drugs|2011Cited by 74
Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).Susan F. Slovin, Eric Ostertag, Xīn Gào et al.|Journal of Clinical Oncology|2022Cited by 51